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Scrub typhus is a severe mite-borne infection caused by Orientia tsutsugamushi, a
obligately intracellular bacterium closely related to Rickettsia. The disease explains a
substantial proportion of acute undifferentiated febrile cases that require hospitalization
in rural areas of Asia, the North of Australia, and many islands of the Pacific Ocean.
Delayed antibiotic treatment is common due to the lack of effective commercially available
diagnostic tests and the lack of specificity of the early clinical presentation. The systemic
infection of endothelial cells that line the vasculature with Orientia can lead to many
complications and fatalities. In survivors, immunity does not last long, and is poorly
cross-reactive among numerous strains. In addition, chronic infections are established
in an unknown number of patients. All those characteristics justify the pursuit of a
prophylactic vaccine against O. tsutsugamushi; however, despite continuous efforts to
develop such a vaccine since World War II, the objective has not been attained. In this
review, we discuss the history of vaccine development against Orientia to provide a clear
picture of the challenges that we continue to face from the perspective of animal models
and the immunological challenges posed by an intracellular bacterium that normally
triggers a short-lived immune response. We finish with a proposal for development of an
effective and safe vaccine for scrub typhus through a new approach with a strong focus on
T cell-mediated immunity, empirical testing of the immunogenicity of proteins encoded by
conserved genes, and assessment of protection in relevant animal models that truly mimic
human scrub typhus.
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INTRODUCTION
Scrub typhus, also known as tsutsugamushi disease [from
Japanese words meaning disease (tsutsuga) mite (mushi)], is a
severe arthropod-borne bacterial infection that is prevalent in a
large geographic area, which extends fromAfghanistan in the west
to Japan, Philippines, and New Guinea in the east, and from the
North of Australia in the south to Russia in the north. The dis-
ease is transmitted by larval trombiculid mites, known as chiggers
(Kitaoka et al., 1974), and is caused by Orientia tsutsugamushi, an
obligately intracellular bacterium thatmainly infects myeloid cells
in the inoculation eschar at the beginning of the infection (Paris
et al., 2012) and subsequently endothelial cells lining the vascu-
lature once the infection becomes systemic (Moron et al., 2001;
Hsu and Chen, 2008). Monocytes and macrophages in all organs
are secondary targets too (Moron et al., 2001). Orientia tsutsuga-
mushi is a strictly intracellular bacterium that resides free in the
cytoplasmof target cells, a characteristic shared by the other genus
of the family Rickettsiaceae, Rickettsia. Orientia first attaches to
target cells, possibly using host surface proteoglycans (Ihn et al.,
2000; Kim et al., 2004) and bacterial surface proteins such as
TSP56 and ScaC (Ha et al., 2011), proteins that can interact
with host fibronectin. This interaction appears to facilitate bac-
terial entry (Lee et al., 2008) via induced phagocytosis (Urakami
et al., 1983) mediated by clathrin (Chu et al., 2006), a process
that could be triggered through integrin α5β1. The subsequent
down-stream signaling leads to cytoskeletal reorganization (Cho
et al., 2010a); orientiae then rapidly escape into the cytoplasm
possibly through enzymatic processes that have not been fully
characterized.
The disease was first reported in the western scientific litera-
ture in 1878 (Palm, 1878) and 1879 (Baelz and Kawakami, 1879).
Although the clinical and pathological similarity with other rick-
ettsioses, specifically with Rocky Mountain spotted fever (caused
by Rickettsia rickettsii), was highlighted as early as 1908 (Asburn
and Craig, 1908), the nature of the etiologic agent was obscure.
The agent of scrub typhus has been studied since 1906, and was
described in detail by Hayashi (1920). Although he believed that
a type of Theileria (a protozoan) caused scrub typhus, his draw-
ings accurately depict the etiological microorganism as we know
it today. In 1924, the agent of scrub typhus was proposed to
be a bacterium (Nagayo et al., 1924), and it was identified as
a Rickettsia by N. Ogata in Japan in 1929 (Sasa, 1967). A clear
demonstration was provided by Nagayo et al. in 1930 using
intraocular injections in rabbits, guinea pigs, and monkeys. They
observed that the organism grows best in endothelial cells of
Descemet’s membrane (Nagayo et al., 1930). The names Rickettsia
tsutsugamushi and R. orientalis were used (Allen and Spitz, 1945)
until 1995 when it was reclassified in a separate genus, Orientia
(Ohashi et al., 1995; Tamura et al., 1995). Until recently, the sole
species of the genus was O. tsutsugamushi; however, a second
species, O. chuto, was discovered in a febrile patient who acquired
the infection in the United Arab Emirates (Izzard et al., 2010),
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and a possible third species may be present in Chile (Balcells et al.,
2011).
Scrub typhus presents as a febrile illness with a spectrum
of severity ranging from mild to lethal. The less severe form
is very difficult to distinguish clinically from murine typhus,
which is highly prevalent in the same geographical areas where
scrub typhus is present. However, early investigators noticed
that murine typhus tends to be a more urban illness while
scrub typhus is more of a rural disease (Lewthwaite and Savoor,
1968). Initial tests with differential agglutinating reactions against
Proteus provided one way to tell them apart (Fletcher et al.,
1929), and, subsequently, indirect immunofluorescence assays
with specific antigens offered a more definitive method to dis-
tinguish them. Immunologically naive patients that acquire scrub
typhus, unlike those with murine typhus, frequently develop
an eschar (area of necrosis and sometimes ulceration) at the
site of inoculation together with regional lymphadenopathy. A
maculopapular rash may or may not be present. The outcome
is determined by multiple factors but the infecting strain of
O. tsutsugamushi is believed to be one of the most important
ones (Kim et al., 2011), and it seems clear that bacterial pro-
liferation (as opposed to immunopathology) and the time of
antibiotic control of the infection are very important predictors
of lethality (Sonthayanon et al., 2009). Indeed, delayed treatment
leads to complications such as adult respiratory distress syn-
drome, disseminated intravascular coagulation, acute renal fail-
ure, meningitis, meningoencephalitis, and gastrointestinal tract
bleeding (Hsu and Chen, 2008; Kim et al., 2011; Yasunaga et al.,
2011).
More than one billion people living in those areas of Asia and
the Pacific, mentioned above are at risk of acquiring the infection
(Watt and Parola, 2003; Watt and Walker, 2006). Where docu-
mented, scrub typhus can account for up to 20% of acute undif-
ferentiated febrile hospitalizations in rural areas (Phongmany
et al., 2006; Suttinont et al., 2006; Kasper et al., 2012). More than
one million cases have been estimated to occur every year; how-
ever, this is surely an underestimation because, given the variety
of strains and the short-lived humoral immunity, seroepidemio-
logical studies must fail to capture all previous cases (Park et al.,
2010). In addition, new areas of endemicity continue to be iden-
tified (Chrispal et al., 2010; Zhang et al., 2010). Scrub typhus has
also had a dramatic impact on exposed soldiers in the eastern
hemisphere sinceWorldWar II, and is now emerging as an impor-
tant disease for travelers to the region (Jensenius et al., 2004;
Nachega et al., 2007). The development of a prophylactic vaccine
to prevent scrub typhus is very important because of at least four
other reasons: (1) mortality from this disease can be very high;
(2) the clinical presentation, particularly early in the symptomatic
period (acute undifferentiated febrile syndrome), is not specific,
making clinical diagnosis very difficult; (3) there are no commer-
cially available diagnostic tests that can be used in the rural setting
during the acute presentation, making on-site laboratory diagno-
sis generally impossible (Koh et al., 2010); and (4) in addition to
natural resistance to many types of antibiotics, including fluoro-
quinolones, penicillins, and aminoglycosides, forms of the disease
that do not respond well to currently recommended antibiotics
(i.e., tetracyclines and chloramphenicol) (Panpanich and Garner,
2002) have been described (Watt et al., 1996; Rosenberg, 1997).
Arguments in support of a renewed effort to develop a vaccine to
prevent scrub typhus are summarized in Table 1.
VACCINES AGAINST SCRUB TYPHUS
Widespread awareness of the importance of scrub typhus arose
with World War II as large numbers of non-immune troops
acquired the disease, sometimes in epidemic proportions, with
mortality as high as 37.5% and prolonged convalescence of more
than 3 months (Megaw, 1945; Philip, 1948). In addition, DDT,
which was extremely effective in killing lice and preventing trans-
mission of epidemic typhus, did not control the mites that
transmit scrub typhus. As a consequence, scrub typhus became a
priority for prevention and/or therapeutic control. In fact, large-
scale production of a vaccine from the processed lungs of cotton
rats infected intranasally with Orientia was undertaken toward
the end of the World War II (Buckland and Dudgeon, 1945).
Evidence of protection provided by this vaccine in humans ini-
tially came from the analysis of 16 cases that received at least
one dose of the vaccine during incubation of naturally-acquired
scrub typhus; all but one of these patients had a mild disease
(Walker, 1947). However, subsequent analysis of cases of scrub
typhus occurring in fully-vaccinated military personnel showed
that severe and nearly fatal cases still occurred and that the inci-
dence was not reduced (Card and Walker, 1947). A later human
field study in Japan did not show evidence of protection after
vaccination with formalin-killed organisms of the Volner strain
of O. tsutsugamushi (Berge et al., 1949). Improvements to the
production method included the use of white rats intravenously
inoculated with yolk sac stock of O. tsutsugamushi (Smadel et al.,
1946). Antigen for vaccination was also produced from frag-
ments of chicken embryos seeded on agar (which presumably
produced chicken embryo fibroblasts) and infected with yolk
sac-cultivated oriental stocks. A formalin-inactivated immuno-
gen was even produced as late as 2006 from chicken egg (yolk
sac)-adapted O. tsutsugamushi (Choi et al., 2006). The prepara-
tion produced protection in mice infected with the same strains
Table 1 | Arguments in support of the development of a prophylactic
vaccine against scrub typhus.
• Scrub typhus is prevalent in a very large geographical area with an
ever-increasing population at risk
• Scrub typhus is responsible for a large proportion of severe
undifferentiated fevers in rural areas of Asia and islands of the Pacific
• Scrub typhus is difficult to diagnose due to the initial non-specific
clinical presentation and the lack of sensitive and specific diagnostic
tests that can be deployed in rural areas during the acute
presentation
• Mortality can be very high if not treated early
• There are many strains of the etiologic agent, Orientia
tsutsugamushi, and those strains do not stimulate an effective
cross-protective immune response
• Experimental infections of humans show that homologous immunity
wanes over time and heterologous immunity is very short-lived
• O. tsutsugamushi is naturally resistant to many actively used
antibiotics
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used for vaccination, but there was no protection against other
strains.
In 1939, Kawamura et al. infected human volunteers with the
Pescadores strain ofO. tsutsugamushi and showed that when chal-
lenged with a very virulent strain, they were solidly protected
(Kawamura et al., 1940). Since the Pescadores strain produces
a very mild disease, this experiment established some proof-of-
concept that an attenuated strain could be an alternative avenue
to pursue for vaccine development against O. tsutsugamushi. On
this topic, it is important to mention that attenuation for mice
may not translate directly to attenuation for humans; for instance,
Jackson et al. discuss that the egg-adapted Gilliam strain is attenu-
ated formice, but produced severe infections in human volunteers
(Jackson and Smadel, 1951). After the discovery of chlorampheni-
col, and its clinical effectiveness in scrub typhus (Smadel et al.,
1949), Smadel et al., tried a somewhat similar approach by infect-
ing with live Orientia followed by antibiotic treatment beginning
1 week after inoculation (Smadel et al., 1951). They observed
appropriate protection against a challenge with the same strain
(Gilliam). Although this homologous protection lasted for at least
14 months in 11 volunteers who were challenged with the same
strain, two did show asymptomatic rickettsemia and one devel-
oped clinical illness. On the other hand, when 10 volunteers where
challenged a year later with the heterologous Karp strain, they
all developed scrub typhus; the disease was immediately treated
with chloramphenicol (Smadel et al., 1952a). It is interesting to
note that some level of immunity might have been present in
the heterologous challenge situation since 4 of 10 immune volun-
teers did not develop eschars while all non-immune controls did
develop eschars (this phenomenonmay explain the lack of eschars
in many cases in endemic regions where previous infection may
have occurred). The eight controls, which were then immune to
the Karp strain, were challenged with the heterologous Gilliam
strain a month later, and three developed scrub typhus.
A modification of the Smadel-induced infection-treatment
method was reported in 1967 (Kekcheyeva, 1967, 1968). In
this case, infection with live O. tsutsugamushi was treated with
tetracycline before vaccination (dubbed chemovaccine or antibio-
vaccine), a procedure that triggered protection without vaccine-
induced mortality in mice. When tested on 21 human volunteers
by subcutaneous inoculation, no skin reactions were observed,
and only a minority of volunteers developed mild fever or local
lymph node tenderness. All volunteers seroconverted; however,
no challenge experiments were performed to evaluate protec-
tion. Eisenberg and Osterman formulated an alternative to the
chemovaccine. It consisted of O. tsutsugamushi irradiated with
300,000 rads (cGy). In the BALB/c mouse model, this pro-
cedure results in complete protection against a homologous
challenge and considerable protection against a heterologous
challenge (Eisenberg and Osterman, 1977), although the het-
erologous protection disappears within 6 months (Eisenberg and
Osterman, 1978). This loss was successfully addressed by vacci-
nating with multiple irradiated strains (Eisenberg and Osterman,
1979). Table 2 summarizes vaccine development efforts for scrub
typhus.
STRAIN DIVERSITY
The issue of Orientia diversity was first suggested from the
epidemiological data demonstrating large differences in sever-
ity of outbreaks depending on geographical location (mortality
rates ranging from 0.6% to 35% in allied forces during WWII)
(Philip, 1948), lack of serological cross-reactivity in some con-
firmed human cases (Philip, 1948), and suggestions of reinfection
in humans (Romeo, 1946; Kuwata, 1952) and non-human pri-
mates (NHPs) (Kouwenaar and Esseveld, 1949). In the report
by Kuwata et al., they included a bibliography in Japanese with
many cases of reinfection reported since 1911. Other studies
characterized the antigenic heterogeneity of O. tsutsugamushi
Table 2 | Vaccines for scrub typhus.
Immunogen Characteristics References
Formalin-fixed homogenized lungs from
Orientia-infected cotton rats
Not effective in humans Buckland and Dudgeon, 1945; Card and
Walker, 1947
Formalin-killed O. tsutsugamushi Not effective in humans Berge et al., 1949
Formalin-killed O. tsutsugamushi Limited homologous protection in mice Bailey et al., 1948; Rights and Smadel, 1948;
Choi et al., 2006
Live strain of O. tsutsugamushi with low
virulence
Solid protection in humans Kawamura et al., 1940
Inoculation of live virulent strain followed
by antibiotic treatment
Protection against homologous strain only and
evidence of persistent infection with immunizing strain
in humans
Smadel et al., 1951; Kekcheyeva, 1967, 1968
Live irradiated O. tsutsugamushi Complete protection against homologous strains and
poor protection against heterologous strains in mice
Eisenberg and Osterman, 1977, 1978, 1979
Recombinant 56-kDa protein Protection against homologous strain in mice Seong et al., 1997a,b
Recombinant fragment of 56-kDa protein Only partial protection against homologous strain in
NHPs
Chattopadhyay et al., 2005
DNA encoding 56-kDa protein Partial protection against homologous strain in mice Ni et al., 2005
Recombinant fusion of 56-kDa and 47-kDa
proteins
Partial protection against homologous strain in mice Yu et al., 2005
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through the use of immune rabbit sera against panels of distinct
isolates of the bacterium by direct immunofluorescence (Shirai
et al., 1979b) or through a plaque reduction assay (Oaks et al.,
1980). Subsequently, after the monoclonal antibody technology
was developed, it became possible to prove that there are antigens
private to each strain (Eisemann and Osterman, 1985; Park et al.,
1993), and phylogenetic analysis of the gene encoding an impor-
tant immunodominant antigen, the 56 kDa protein (or TSP56),
showed different levels of homology among many strains (Ohashi
et al., 1996; Enatsu et al., 1999; Ruang-Areerate et al., 2011).
A recent analysis of the sequences of genes encoding surface anti-
gens (sca) from four strains ofO. tsutsugamushi showed that there
are variable levels of conservation and even absence of some genes
in some strains (Ha et al., 2012). The predominance of sequence
variation at the level of surface genes had already been noted
when the two fully sequenced O. tsutsugamushi genomes (strains
Boryong and Ikeda) were analyzed (Nakayama et al., 2008, 2010).
In fact, the genomic evidence suggests that transposable elements
have continued their amplification and decay after divergence of
the two sequenced strains. This may explain the extreme degree
of genome shuffling that is evident when the two strains are
compared.
NATURALLY ACQUIRED IMMUNITY IS SUBOPTIMAL
In 1950, the lack of solid immunity in humans was confirmed
through inoculation of volunteers. In this study, 11 of 16 volun-
teers who had scrub typhus (11–25 months earlier) developed
scrub typhus of similar severity as controls after subcutaneous
inoculation of O. tsutsugamushi, Gilliam strain (Smadel et al.,
1950). The fact that none of eight volunteers who had scrub
typhus 1–2 months earlier developed the disease again upon
rechallenge suggested that immunity is established but that it
wanes rapidly. Most of the original infections were believed to
have been caused by strains of O. tsutsugamushi different from
Gilliam (therefore, this was likely a heterologous challenge). In
one volunteer from the same study, it was known that the first
infection was caused by the same strain of O. tsutsugamushi used
for the challenge more than 3 years later; this person devel-
oped no other symptoms besides localized erythema at the site of
inoculation. Furthermore, in another study, a homologous chal-
lenge was performed on one individual three and a half years
after the first infection, and protection was complete (Smadel
et al., 1952a). The picture that emerged from these studies was
that, in humans, heterologous immunity is very short-lived while
homologous immunity may be long-lasting. This picture is also
supported by experiments with NHPs. MacMillan et al., showed
that cynomolgus monkeys are susceptible to the homologous
strain of O. tsutsugamushi when re-infected 5–6 years after the
first infection, but not when rechallenged 8 months after the first
infection (MacMillan et al., 1985). In contrast to these studies
with humans and NHPs, some early studies showed that het-
erologous immunity in gerbils is strong even after 6–9 months
following initial infection and antibiotic treatment with para-
aminobenzoic acid (Zarafonetis et al., 1946). Similar findings
were reported for guinea pigs (Topping, 1945a) including, in one
study, challenges performed nearly 2 years after the initial infec-
tion (Kouwenaar and Esseveld, 1949). It is probable that gerbils
and guinea pigs are particularly resistant to infection with O. tsut-
sugamushi; indeed, that was the experience of early investigators
(Lewthwaite and Savoor, 1968).
HOMOLOGOUS vs. HETEROLOGOUS IMMUNITY
The disparity between protection against heterologous oriental
strains stimulated by infection followed by recovery, albeit short-
lived, and the lack of heterologous protection afforded by vac-
cines (Rights and Smadel, 1948) or immune serum (antibodies)
was evident to early investigators, but the possible implications
could not have been forecasted without a better understand-
ing of the mechanisms of immunity, particularly the role of
cellular immunity, which was only first investigated for scrub
typhus in 1976 (Shirai et al., 1976). In the study by Rights
and Smadel, formalin-killed vaccines prepared from rat lungs
and spleens stimulated complete protection against a lethal
intraperitoneal challenge with the homologous strain and vari-
able protection against seven other strains with a range from
significant protection to absolutely no cross-protection. It should
be noted, however, that even mice challenged with the homolo-
gous strain developed illness (although they were protected from
dying). It is also notable that subcutaneous immunization with
formalin-inactivated organisms did not provide protection even
against the homologous strain; vaccination and challenge had to
be done through the same route, intraperitoneally (Bailey et al.,
1948). This is in contrast to live O. tsutsugamushi, which provides
homologous protection when used for priming via the subcuta-
neous route (Shishido et al., 1958, 1959). Another study showed
that, mice are susceptible to a heterologous challenge during the
course of an acute oriental infection (Kuwata, 1952); after day 8
of the acute infection, these mice did not succumb to the heterol-
ogous O. tsutsugamushi, but the heterologous O. tsutsugamushi
organisms could be isolated from these mice; therefore, superin-
fection can occur. This finding appears to be relevant to humans
because there is evidence that humans can harbormultiple strains
of O. tsutsugamushi during a single clinical episode (Elisberg
et al., 1967). Unfortunately, there is very little information about
the nature of the anti-oriential immune response in individuals
from endemic areas that may frequently be exposed to multiple
strains.
PERSISTENCE OF O. tsutsugamushi
For mice, the phenomenon of bacterial persistence was first
reported as a Pers. communication from Fox and Peterson to
Zarafonetis (Zarafonetis et al., 1946). These authors questioned
whether the chronic infection stimulates an “interference phe-
nomenon” (i.e., activated innate immunity) that could explain
the initial heightened immunity. Kowenaar, et al. mention in
one of their studies that O. tsutsugamushi could be found in
the urine of humans and guinea pigs even after the end of
the symptomatic period (Kouwenaar and Esseveld, 1949). They
were able to recover these bacteria from various tissues and
fluids of guinea pigs up to 635 days post-infection. Fox demon-
strated persistence in mice inoculated i.p., with the Karp strain
of O. tsutsugamushi (treated with toluidine blue to prevent their
death) by inoculating brain or liver (of animals sacrificed up
Frontiers in Cellular and Infection Microbiology www.frontiersin.org January 2013 | Volume 2 | Article 170 | 4
Valbuena and Walker Vaccines for Orientia
to 62 days later) and blood or kidney suspensions (of animals
sacrificed up to 320 days later) into naive mice (Fox, 1948).
Also, live O. tsutsugamushi was found in most organs of ani-
mals treated with methylene blue up to 496 days later. Similarly,
in cotton rats, persistence was identified up to 3 months after
inoculation.
In a later study in 1964, Kundin et al. tested various stress
methods (including irradiation and corticosteroids) to elicit
recrudescence from mice infected 1 year earlier with O. tsut-
sugamushi via the subcutaneous route (Kundin et al., 1964).
Although they were able to recover O. tsutsugamushi from 20
to 25 stressed mice, they accomplished the same (13 of 14
mice) from control unstressed mice. A subsequent study used
cyclophosphamide to reactivate the Orientia 19 months after the
initial infection (Shirai et al., 1979a). In humans, Smadel et al.
reported the isolation of O. tsutsugamushi from an enlarged axil-
lary lymph node of a person who had recovered clinically from
scrub typhus 15 months earlier. The organism was recovered
from mice inoculated intraperitoneally with the supernatant of
a homogenate of the lymph node. Similar attempts in 11 other
volunteers that had recovered from scrub typhus were unsuc-
cessful (Smadel et al., 1950, 1952b). Interestingly, the positive
lymph node was very fibrotic with almost complete absence of
lymphoid follicles and with prominent thick-walled blood ves-
sels. This volunteer was also challenged with the Gilliam strain
of O. tsutsugamushi immediately after the lymph node extrac-
tion and also 18 months later; on both occasions, no signs of
illness developed. In NHPs, O. tsutsugamushi can also be recov-
ered from draining and non-draining lymph nodes of otherwise
healthy convalescent animals (Walker et al., 1973). In addition,
clinically healthy NHPs that had recovered from scrub typhus
were not only susceptible to a heterologous challenge, but also
showed evidence of recrudescence of the original strain used
for the initial infection (Robinson et al., 1981). This finding
is very interesting because there is very suggestive evidence of
infection of humans with more than one strain of O. tsutsug-
amushi (Elisberg et al., 1967, 1968; Sonthayanon et al., 2010),
which could be explained by either recrudescence of an origi-
nal infection after reinfection with a heterologous strain or by
simultaneous infection with different strains. In turn, this latter
possibility could be explained by bites from different chiggers,
each one infected with only one strain or, alternatively, by the
bite of individual chiggers infected with multiple strains. There
is indeed evidence that individual chiggers can be infected with
multiple strains (Shirai et al., 1982a,b). Most recently, Chung
et al. were able to isolate O. tsutsugamushi from the blood of six
convalescent patients 1–18 months after the initial diagnosis and
treatment with azithromycin, doxycycline, or a combination of
antibiotics (Chung et al., 2012). All these data strongly suggest
that scrub typhus is a chronic infection in an unknown propor-
tion of patients. An additional and very important implication
of the simultaneous infection of hosts and chiggers by different
strains of O. tsutsugamushi is that lateral gene transfer becomes
a possibility that could drive the evolution of Orientia and the
further diversification of strains. This possibility is supported by
recent genomic analyses of multiple strains (Duong et al., 2010;
Sonthayanon et al., 2010).
The underlying mechanisms of persistence are not known.
There clearly are pathogen factors, but host factors related to the
immune response must also be in play. In this regard, it has been
suggested that the slow development of T cell effector responses
may be causally related to the establishment of chronic infections
(Miller et al., 2008).
EFFECT OF THE VECTOR
Although the native people of endemic areas were keenly aware
of the transmission of scrub typhus by chiggers (Blake et al.,
1945), the concept of transmission by mites was first established
in the scientific literature by Tanaka in 1899 based on clinical
observations and intimate familiarity with the disease as he was
a physician practicing in an endemic area of Japan (Sasa, 1967).
Only the larval stage of Leptotrombidium mites (chiggers) para-
sitizes vertebrate hosts by feeding on lymph and tissue fluids of
the dermal layer (but not blood) for a period of 2–4 days (Philip,
1948). Infected mites maintain the infection through transtadial
and transovarial transmission (Phasomkusolsil et al., 2009). In
a large proportion of immunologically naive patients, an eschar
develops at the bite site. It is very likely that chiggers, just like
ticks (Francischetti et al., 2009), have immunomodulatory fac-
tors in their saliva that could affect the outcome of the disease;
however, this remains an unexplored area. Clues of those effects
could be obtained from the study of eschars from human cases.
Indeed, a recent study of 11 eschars from patients with con-
firmed scrub typhus confirmed the classic histological finding
of epidermal necrosis and ulceration accompanied by signifi-
cant neutrophilic infiltration adjacent to the area of necrosis and
mononuclear cell infiltrates in the dermis (Lee et al., 2009; Paris
et al., 2012). Those infiltrates consisted of T cells, monocytes, and
dermal dendritic cells. In fact, monocytes, dermal dendritic cells,
and Langerhan’s cells were found to be infected with O. tsutsug-
amushi as judged by confocal microscopic analysis. In contrast,
infection of endothelial cells was extremely rare in the eschars.
Studies of mites are complicated by their size and the diffi-
culty of breeding them given that the nymph and adult stages do
not feed on blood. The first successful breeding was reported in
1951 using mosquito eggs as food as for the late developmental
stages of these mites (Sasa, 1967). Subsequently, the experimen-
tal transmission of O. tsutsugamushi to humans (Shirai et al.,
1982b) and ICR mice (Shirai et al., 1982a) using chiggers was
reported. Notably, chiggers from the same colonies that produced
classic scrub typhus in humans produced minimal morbidity
in mice and NHPs. Most recently, it was shown that even one
chigger was sufficient to accomplish the infection of ICR mice
(Lurchachaiwong et al., 2012). One species of chiggers transmit-
ted a strain ofO. tsutsugamushi with near complete lethality while
two other different mite species transmitted a strain that caused
death of about half of the exposed mice. However, it is not pos-
sible to determine whether the differential mortality is due to
differences in the vector since the strains ofO. tsutsugamushi were
not the same in different chigger lines.
ANIMAL MODELS
The earliest experiments with both mite bite and percutaneous
infections were performed by Hayashi using NHPs and guinea
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pigs (Hayashi, 1920). Subsequently, the majority of published
studies have used mice infected with O. tsutsugamushi via the
intraperitoneal route, which produces an intense localized infec-
tion of the peritoneum and all serosal surfaces within it (Ewing
et al., 1978), but not a significant disseminated endothelial infec-
tion, which is the hallmark of human scrub typhus (Moron et al.,
2001). In fact, infection of mesothelial cells, which line serosal
surfaces in the peritoneum, produces a cycle of infection where
membrane-enclosed orientiae bud from infected cells and these
host membrane-bound bacteria enter, via phagocytosis, other
mesothelial cells (Ewing et al., 1978). Whether this same cycle is
operational in the true target cells of O. tsutsugamushi has not
been investigated.
Not unexpectedly, different mouse strains have different
degrees of susceptibility to oriental infection (except for the Karp
and Kato strains that are equally lethal for all mouse strains) via
the i.p. route (Groves and Osterman, 1978) with C3H mice being
the most susceptible (as determined with the Gilliam strain).
That susceptibility appears to be linked to a single locus (Ric)
on chromosome 5 (Groves et al., 1980) where the gene for early
T lymphocyte activation 1 (Eta-1, better known as osteopon-
tin) is located (Patarca et al., 1989). Indeed, different alleles of
this gene are present in resistant and susceptible mouse strains;
susceptible mice show a very delayed increase in this gene’s
product as compared to resistant mice, which respond within
1 day.
In contrast to macrophages from BALB/c mice, those of C3H
mice migrate to the infected peritoneum with delayed kinetics,
do not become activated, and are much more susceptible to ori-
ental infection once in the peritoneum (Nacy and Groves, 1981).
Since C3Hmacrophages can be activated in vitro to killO. tsutsug-
amushi in a similar fashion as macrophages from BALB/c mice,
the problem appears to be one of regulation of macrophage func-
tion. When congenic C3H strains that differ only in the Ric locus
were compared, the strain with the locus derived from resistant
mice (C3H/RV, which is also known to have a better interferon
response) was resistant to a lethal challenge with Gilliam strain
(Jerrells and Osterman, 1981), and the main difference was that
there was a large influx of neutrophils on days 5 and 10 in the
susceptible mice, but not in the resistant mice, which suggests
that neutrophils could be associated with ineffective immunity.
In addition, all infiltrating cells (particularly macrophages and
lymphocytes) supported oriental growth while very few of the
peritoneal infiltrating cells of resistant mice were infected. It is
very interesting to note that Gilliam strain-resistant C3H/RV
mice responded to i.p., Karp strain infection with a large influx
of neutrophils. In contrast with the differences observed with
i.p inoculation, C3H/RV and C3H/He were both resistant to an
intravenous inoculum of Gilliam strain that is consistently lethal
when given i.p., to C3H/He mice (Jerrells and Osterman, 1982a).
These mice developed strong immunity. With a 10-fold higher
dose, however, C3H/He mice died after intravenous inoculation
of Gilliam strain but not C3H/RVmice. When macrophages were
depleted with silica or carrageenan (i.v.), C3H/He mice became
susceptible to lethality with the lower i.v. inoculumwhile C3H/RV
mice remained resistant. Thus, monocytes and macrophages
appear to play a complex role in immunity against Orientia; they
are both targets of oriental infection as well as potential effectors
of bacterial killing.
As for other routes of experimental infection, intracerebral
inoculation produces a localized infection in the brain while
intramuscular or subcutaneous infections result in systemic infec-
tions, but this effect depends on the virulence of the Orientia
strain used (Kundin et al., 1964). Importantly, the subcutaneous
route causes a chronic infection with rickettsemia detectable for at
least 52 weeks after the initial infection (Groves and Kelly, 1989).
This phenomenon is associated with maintenance of high levels
of specific antibodies.
Rhesus macaques have also been used to study scrub typhus
(Morris, 1965). Although it appears that most macaques are resis-
tant to infection with O. tsutsugamushi, this resistance is probably
due to previous infection as indicated by a high seroprevalence
(Heisey et al., 1981). For this reason, Walker et al. developed a
model with silvered leaf-monkeys given that they are not likely to
be exposed to chiggers in nature since they are arboreal. When
infected subcutaneously, these NHPs developed a disease resem-
bling human scrub typhus including formation of an eschar at
the inoculation site, draining node lymphadenopathy, fever with
a peak in the third week post-inoculation, low mortality (2 of 14
NHPs), seroconversion in surviving animals, and persistence of
O. tsutsugamushi in lymph nodes at 2 months after clinical recov-
ery in 11 of 12 monkeys and 5 months later in 1 of 2 monkeys
(Walker et al., 1973). The duration of fever was longer with the
Gilliam strain than Karp or Kato strains. Subsequent studies with
this model showed that specific antibodies were not detectable
14 months after the initial challenge in 17 of 18 monkeys and
that they were no longer protected when challenged with homol-
ogous or heterologous strains of O. tsutsugamushi, although the
disease was less severe than that of naive controls (Robinson et al.,
1981). Subsequently, when seronegative cynomolgus macaques
were studied, it was found that they also constituted an excellent
model that faithfully mimicked human scrub typhus (MacMillan
et al., 1985), including the histopathological characteristics of the
inoculation eschar (Walsh et al., 2007).
THE ROLE OF ANTIBODIES IN IMMUNITY AGAINST Orientia
Early experiments suggested that antibodies can be protective if
present early in the disease course as demonstrated through pas-
sive transfer of serum from immune rabbits to mice infected with
a lethal intraperitoneal inoculum ofO. tsutsugamushi, Karp strain
(Topping, 1945b). Some of the mice were completely protected,
and death was delayed in the rest of the animals when the immune
serum was provided as late as 168 h post-infection. Optimism
about the use of serum therapy in humans was based on the
thought that the inoculation eschar would provide an early sign
of the disease to trigger this therapy at a point in the course when,
as judged from experiments performed with Rocky Mountain
spotted fever in humans, it is most effective. On the other hand,
early experiments with the complement-fixation test showed that
when strain-specific antisera (from guinea pigs and humans) were
titrated against homologous or heterologous strains of O. tsut-
sugamushi, the end-point titers against the homologous strain
were always considerably higher than the end-point titers against
the heterologous trains (Bengston, 1945; Bailey et al., 1948).
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Similar results were obtained when neutralization was used as
the readout of the experiment (Bennett et al., 1949; Hanson,
1983). In addition, animal experiments with immune sera against
different strains showed that neutralization is complete for the
homologous strain but does not provide protection against chal-
lenges with heterologous strains (Bell et al., 1946). One of the
implications of those studies is that diagnostic serological tests
are much more sensitive for the detection of antibodies against
the homologous strain. The other implication is that heterolo-
gous antibody-mediated cross-immunity may not be as potent
as homologous immunity. Moreover, anecdotal evidence from
human cases indicates that convalescent serum did not impact
the progression of the disease (Philip, 1948). Similarly, in guinea
pigs, immune serum (from either humans or guinea pigs) did not
yield a favorable outcome (Kouwenaar and Esseveld, 1949). An
additional issue with humoral immunity in humans is that spe-
cific antibodies, as measured by indirect fluorescence assay (IFA)
in one study, become undetectable in 40 months (Saunders et al.,
1980). The decrease in specific antibody titers against O. tsut-
sugamushi was also recently confirmed in humans (Kim et al.,
2010). In NHPs, antibodies are lost within 1 year (MacMillan
et al., 1985). These findings are very important not only in terms
of protective immunity, but also in terms of the outcomes of
seroepidemiological studies that may, in consequence, underes-
timate the actual prevalence of scrub typhus. Finally, although
the antibody response transitions from IgM early after an acute
infection of naive individuals (both humans and experimental
animals) to IgG, systematic studies of immunoglobulin isotypes
and the influence of their effector functions (e.g., complement fix-
ation and antibody-dependent cytotoxicity) on disease outcomes
have not been undertaken.
THE ROLE OF T CELLS IN IMMUNITY AGAINST Orientia
The observation of delayed hypersensitivity after experimental
immunization suggests a role for cell-mediated immunity (Jerrells
and Osterman, 1982a). One of the first suggestions of the impor-
tance of cell-mediated immunity came from studies with the
Gilliam strain of O. tsutsugamushi, which is less virulent than the
Karp strain in BALB/c mice infected by intraperitoneal infection
(Catanzaro et al., 1976). In this model, after mice recover from the
initial infection with Gilliam strain, they do not have antibodies
that cross-react with Karp strain; however, they resist a challenge
with the Karp strain (Shirai et al., 1976). Furthermore, transfer
of anti-Gilliam serum did not confer protection against a lethal
challenge with Karp strain; however, passive transfer of spleno-
cytes (depleted of plastic adherent cells, mainly macrophages)
from Gilliam-immune mice to naive mice produced complete
resistance against a lethal challenge with Karp strain when the
splenocytes were derived from mice infected with Gilliam strain
2–3 weeks earlier and 80% protection when the splenocytes came
from mice infected with Gilliam strain 42 or 63 days earlier.
The protective effect was abrogated when the cells to be trans-
ferred were depleted of T cells. In a subsequent study by the
same group, they were able to use the Karp strain for immu-
nization via the i.p., route without causing lethality in mice if
the bacteria were gamma-irradiated with a dose that keeps the
bacteria alive (as demonstrated by their ability to enter cells
in vitro) but prevents their replication (Eisenberg and Osterman,
1977; Eisenberg et al., 1980). They reported complete homolo-
gous protection and significant heterologous protection against
lethal challenges, and, as in the earlier study, the protection
was cell-mediated. Interestingly, splenocytes from animals immu-
nized with formalin-inactivated O. tsutsugamushi did not confer
any protection against either the homologous or heterologous
strains after adoptive transfer into naive animals, suggesting that
T cell-mediated immunity is not developed with this type of
immunization. These results seem to explain the results of early
studies and trials with formalin-inactivated O. tsutsugamushi.
NHPs also demonstrate antigen-specific proliferation of lym-
phocytes from peripheral blood against both homologous and
heterologous antigens (MacMillan et al., 1985); however, unlike
mice, the response declined with time. From the perspective of
current knowledge in immunology, this could be due not to loss
of responding cells but to migration of memory T cells to rele-
vant organs, which, in consequence, would not be detectable in
peripheral blood. From human cases, we know that during the
acute phase of scrub typhus (on admission to the hospital) there
is elevation of several cytokines such as IFN-γ, IL-18, IL-12(p40),
TNF-α, T cell-targeting chemokines (CXCL9 and CXCL10), and
of granzymes A and B, which are indicators of NK cell or CD8+
T cell activation, or both (Iwasaki et al., 1997; Chierakul et al.,
2004; de Fost et al., 2005). Recent studies of patients with scrub
typhus have shown elevation of other cytokines besides those just
mentioned including IL-1β, IL-10 (Kramme et al., 2009), and
IL-6 (Chung et al., 2008). Also, in C3H/HeN mice infected i.p.,
with Gilliam strain, these and other cytokines and chemokines
(RANTES, Mip1-a, Mip-1b, Mip-2, MCP-1) were identified in
peritoneal lavages with peaks that coincided with the degree
of leukocyte infiltration (Koh et al., 2004). The levels of these
cytokines were higher in susceptible C3H mice than in resistant
BALB/c mice (Yun et al., 2005). It is likely that intracellular sens-
ing of orientiae in target cells contributes to cytokine secretion. In
this regard, it was recently shown that in O. tsutsugamushi infec-
tion of endothelial cells the intracellular innate receptor NOD1
leads to production of IL-32, which in turn regulates the pro-
duction of other cytokines and adhesion molecules (Cho et al.,
2010b). The significance of the above findings related to cytokines
and chemokines depends on the kinetics and interactions of
the various components within the context of the entire system
in vivo, and this systems approach has not yet been attempted.
The information presented above supports the concept that
the anti-oriential humoral immune response is very poorly cross-
reactive or not cross-reactive at all for different strains of O.
tsutsugamushi, while the T cell response is significantly cross-
reactive. Jerrells and Osterman provided further supportive evi-
dence in 1983 when they demonstrated that lymphocytes from
immunized animals proliferate in response to both homolo-
gous and heterologous oriental antigens (Jerrells and Osterman,
1983). The responding lymphocytes were T cells based on lack
of adherence to nylon wool, response to concanavalin A, and
lack of response after depletion with anti-Thy1.2 serum. A sub-
sequent study showed that these T cells produced cytokines,
including interferon (Jerrells et al., 1983), more specifically,
IFN-γ (Palmer et al., 1984a,b), which, based on the timing and
Frontiers in Cellular and Infection Microbiology www.frontiersin.org January 2013 | Volume 2 | Article 170 | 7
Valbuena and Walker Vaccines for Orientia
magnitude of its peak level, was one of the first cytokines to
be considered very important (Palmer et al., 1984a). Similarly,
NHPs’ T cells also respond to oriential infection with produc-
tion of IFN-γ (MacMillan et al., 1985). The in vivo relevance
was further supported by the protection provided with immune
IFN-γ-producing T cells transferred into naive mice (Kodama
et al., 1987). Despite the apparent importance of T cell-mediated
immunity in the anti-oriential response, it is interesting to note
that patients with HIV infection do not develop a more severe
form of scrub typhus (Kantipong et al., 1996). In fact, scrub
typhus results in a decrease in HIV replication as determined by
a comparison of viral loads in HIV-positive patients with scrub
typhus vs. HIV-positive patients with other infections (Watt et al.,
2000).
Of course, a physiological immune response against an obli-
gately intracellular microbe includes a combination of anti-
bodies and cell-mediated immunity that work together. The
importance of this synergistic interaction is suggested by the
comparison of the level of protection stimulated by vaccina-
tion with irradiated bacteria vs. that induced by live bacteria.
Mice immunized with irradiated bacteria produced very little
antibody and, although completely protected, had orientemia
after challenge. On the other hand, mice immunized subcuta-
neously with live non-irradiated bacteria had much higher level
of antibodies and did not manifest orientemia after a homol-
ogous challenge (Jerrells et al., 1983). Also, it is now clear
that effective antibody responses are T cell-dependent; this was
first demonstrated in studies with athymic mice which were
protected by transfer of immune T cells, and only when this
transfer was performed did mice develop a humoral immune
response (Kobayashi et al., 1985). Table 3 summarizes the
characteristics of the natural adaptive immune response against
O. tsutsugamushi.
EFFECTORS OF ORIENTIAL KILLING
Early in vitro experiments with macrophages showed that these
cells could kill O. tsutsugamushi when activated by cytokines
present in supernatants of activated splenocytes (Nacy and
Meltzer, 1979; Nacy et al., 1983). Indeed, peritoneal macrophages
from mice infected with O. tsutsugamushi (Gilliam strain) 9 days
earlier were considerably more resistant to in vitro infection
due, most likely, to their activated status (Nacy and Osterman,
1979). Furthermore, when immune serum was present in the
assay, there was enhanced uptake and killing of Orientia, indi-
cating that Fc receptor-mediated uptake of opsonized bacteria
may be an important mechanism of oriential clearance. Also,
non-specific activation of intraperitoneal macrophages confers
protection to an otherwise lethal inoculum (Nacy and Meltzer,
1984). Notably, however, in vitro Karp strain infection of peri-
toneal macrophages from C57BL/6 mice did not result in sig-
nificant TNF-α production while it did when they were infected
with Rickettsia conorii (Jerrells and Geng, 1994). On the other
hand, when TNF-α is provided exogenously, macrophages acquire
the ability to inhibit the growth of O. tsutsugamushi in vitro
(Geng and Jerrells, 1994). In contrast with the previous data,
there is evidence that activated macrophages can mediate, at
least in part, transient immunosuppression that is observed up
to 1 month after subcutaneous challenge of BALB/c mice with
Karp strain, which is, as explained earlier, a chronic infection
model (Jerrells, 1985). In thesemice, lymphocytes had a decreased
Table 3 | Adaptive immune response against O. tsutsugamushi.
Species Study findings References
Humans Homologous immunity lasts up to 3.5 years but heterologous immunity
lasts only a few months
Smadel et al., 1950, 1952a,b
Humans can be infected by multiple strains simultaneously Elisberg et al., 1967, 1968; Sonthayanon et al., 2010
Oriential infections in humans can be chronic Kouwenaar and Esseveld, 1949; Smadel et al., 1950,
1952a,b Chung et al., 2012
Humoral immunity, even against the homologous strain, is short lived Saunders et al., 1980; Kim et al., 2010
Non-human
primates
Homologous immunity is non-existent after 5 years MacMillan et al., 1985
Oriential infections in NHPs can be chronic Walker et al., 1973
A heterologous oriential infection can induce recrudescence of a prior
infection
Robinson et al., 1981
Humoral and cellular immunity are short lived MacMillan et al., 1985
Rodents Heterologous protection is present 9 months after infection in gerbils Zarafonetis et al., 1946
Heterologous protection is present 2 years after infection in guinea pigs Topping, 1945a; Kouwenaar and Esseveld, 1949
Mice can be infected by a different oriential strain during the course of
an acute oriential infection
Kuwata, 1952
Oriential infections in mice can be chronic Zarafonetis et al., 1946; Fox, 1948; Kundin et al., 1964;
Shirai et al., 1979a
Antibodies provide homologous protection but are poorly
cross-protective
Bengston, 1945; Topping, 1945b; Bell et al., 1946;
Bailey et al., 1948; Bennett et al., 1949; Hanson, 1983
T cells provide homologous protection and significant heterologous
protection. IFN-γ− is a particularly important effector cytokine
Eisenberg and Osterman, 1977; Eisenberg et al., 1980;
Jerrells and Osterman, 1983; Kodama et al., 1987
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proliferative response to concanavalin A stimulation, to an unre-
lated model antigen and to alloantigens in a mixed lymphocyte
reaction, and those defects could be corrected by depleting
adherent cells (macrophages); furthermore, macrophages from
infected mice (before day 28 post-infection) could inhibit the
response of normal splenocytes to mitogens. This effect could
be inhibited with indomethacin; thus, prostaglandins were likely
playing a role. More recently, a global transcriptome analy-
sis of human monocytes infected in vitro with O. tsutsuga-
mushi for 8 h in comparison with uninfected monocytes was
reported (Tantibhedhyangkul et al., 2011). Thousands of genes
participating in many cellular processes changed their expres-
sion. The authors highlighted the type I IFN response and the
expression of an M1 program (a pro-inflammatory phenotype)
because of their importance in the regulation of the immune
response. Furthermore, many of the genes that changed expres-
sion significantly were also identified in a transcriptome anal-
ysis of peripheral blood mononuclear cells from four patients
with confirmed scrub typhus. All these studies with mono-
cytes and macrophages are relevant since these cells are not
only effectors of immunity, but also secondary targets of ori-
ential infection in humans (Moron et al., 2001). Knowledge
of the responses of the primary early target (dendritic cells)
and the major disseminated target (endothelial cells) would
expand understanding of the innate and adaptive immunity to
O. tsutsugamushi.
ANTIGENS AND THE PURSUIT OF SUBUNIT VACCINES
Characterization of antigens from O. tsutsugamushi was first
approached with SDS-PAGE separation of lysates of purified
bacteria (or membrane fractions) followed by elution from indi-
vidual gel slices and ELISA with the eluate and sera from immune
mice (Eisemann and Osterman, 1981). They identified six major
immunoreactive fractions on the membranes and showed anti-
gens that were common to three strains, but also some antigens
that were recognized exclusively by homologous immune sera.
A subsequent study using immunoprecipitation of radiolabeled
proteins of Orientia showed that the most abundant proteins
were also the ones recognized by immune sera (Hanson, 1985).
Today, using Western blot, we know that there are five proteins of
O. tsutsugamushi that are clearly immunodominant to humans.
They have molecular weights of 22 kDa, 47 kDa, 56 kDa, 58 kDa,
and 110 kDa (Chen et al., 2011). It is also important to point
out that orientiae do not have peptidoglycan or LPS in their
cell wall (Amano et al., 1987), which in other bacteria provide
cross-reactive and protective antigens.
The first step toward the production of a subunit vaccine for
scrub typhus was accomplished with the cloning and expres-
sion of two major immunoreactive proteins from the Karp strain
of O. tsutsugamushi, the 110 kDa and 56 kDa oriential proteins,
which are cross-reactive with homologous antigens in two other
stains, Kato and Gilliam (Oaks et al., 1987; Stover et al., 1990a,b).
Cloning the 56 kDa protein was very important because all con-
valescent sera from humans that had suffered scrub typhus have
antibodies against this protein as determined by Western blot.
Nevertheless, strain-specific epitopes were identified usingmono-
clonal antibodies (Stover et al., 1990a) and deletion constructs of
this gene (Choi et al., 1999); indeed, evidence from the amino acid
sequences of multiple strains indicated that the 56 kDa protein
has four major variable domains that result in different alleles for
each strain (Ohashi et al., 1992). Antigens of 11 kDa and 58 kDa
were cloned shortly thereafter and shown to be heat shock pro-
teins recognized by the sera of humans who previously had scrub
typhus (Stover et al., 1990b). The 58 kDa protein was considered
of major interest because of its potential high-degree of conser-
vation among different strains of O. tsutsugamushi. In 1991, the
cloning of a 22 kDa protein from the Karp strain was accom-
plished; this protein was recognized by both antibodies and a
CD4+ T cell line generated from mice immune to Karp strain
(Hickman et al., 1991). This achievement was followed by the
cloning of a 47 kDa antigen and the recognition of its ability
to stimulate a similar anti-O. tsutsugamushi mouse CD4+ T cell
line (Hickman et al., 1993). This study also reported a 20 amino
acid peptide from this protein that specifically stimulated this
T cell line.
Polyclonal hyperimmune serum from rabbits infected with
O. tsutsugamushi inhibits entry of a homologous strain into tar-
get cells in vitro without dependence on complement activity
(Hanson, 1983). Related subsequent investigations showed that
antibodies produced in mice and rabbits against the recombi-
nant 56 kDa protein from the Boryong strain inhibit attachment
and penetration of mouse fibroblasts (Seong et al., 1997a). This
finding prompted the authors to test it as a vaccine, and they
found that i.p., immunization of C3H/HeDub mice with this
recombinant protein, with alum as adjuvant, provided protec-
tion against otherwise lethal inocula of the homologous strain
(Seong et al., 1997b). Part of the response was likely mediated
by T cells as indicated by antigen-specific proliferation of lym-
phocytes from immune animals; these cells produced IL-2 and
IFN-γ. High titer antibodies were also produced. In addition,
another study demonstrated that certain monoclonal antibodies
against the 56 kDa protein neutralized infection by a homologous
O. tsutsugamushi strain inoculated i.p. (Seong et al., 2000). In
cynomolgus monkeys, a truncated recombinant fragment from
the 56 kDa protein of Karp strain, adjuvanted with Montanide
ISA 51 and CpG 10103, stimulated production of appropriate
antibody and T cell responses; however, it did not prevent the
development of rickettsemia upon challenge 1 month after vac-
cination. In contrast, prior infection yielded complete immunity
(Chattopadhyay et al., 2005). The 56 kDa antigen was also studied
in the form of a DNA vaccine, which resulted in 60% survival of
the challenged outbredmice after four intramuscular injections of
the DNA (Ni et al., 2005). When the 56 kDa protein was expressed
as a fusion protein with the 47 kDa antigen and used for immu-
nization (in a Karp strain model), survival was better than that
produced by either one of the two recombinant proteins (Yu et al.,
2005), suggesting that a multisubunit vaccine could be a poten-
tially successful approach. However, in this case, a whole cell lysate
of Karp strain provided the best protection.
MODERN VACCINOLOGY CONCEPTS APPLIED TO SCRUB
TYPHUS
We recently reviewed some general principles of immunity and
vaccine development, as it applies to Rickettsia (Valbuena, 2012);
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thus, we will mainly emphasize those that are particularly per-
tinent to Orientia (Table 4). The earliest attempts to develop a
vaccine against scrub typhus have not been successful because
they have not directly addressed two important characteristics of
this infection, namely the significant antigenic variation among
strains of O. tsutsugamushi and the limited cross-protective
immunity that natural infections trigger against heterologous
strains. The most recent approaches to vaccine development
have focused on antigens that are immunodominant for the
humoral immune response, and those attempts have used the
previous paradigm of vaccinology, the trial-and-error approach.
We believe that those studies have met with very limited suc-
cess because they failed to consider the fact that scrub typhus is
an intracellular infection for which cellular immunity is critical.
Those studies also overlooked the fact that oriential immun-
odominant antigens do not trigger sterilizing protective immu-
nity in a still unknown proportion of humans who develop a
chronic infection with O. tsutsugamushi. Furthermore, there are
data supporting the concept that antibodies, CD4+T cells, and
CD8+T cells target different antigens (Moutaftsi et al., 2007).
Thus, antigen identification through antibodies does not neces-
sarily detect antigens recognized by CD4+T cells or, particularly,
CD8+T cells.
Advance toward development of a clinically effective vaccine
against scrub typhus is currently hampered by many barriers;
among them are the following: (1) the lack of comprehensive
knowledge of antigens that are common to different O. tsutsug-
amushi strains and that, as a whole, can stimulate broad branches
of the adaptive immunity (both cellular and humoral); (2) the
limited knowledge about the signature markers (i.e., correlates of
protection) of cross-protective immunity, an aspect that is com-
plicated by the chronicity of the infection; and (3) the lack of
appropriate small animal models for vaccine testing that recapit-
ulate the systemic endothelial infection observed in humans and
the percutaneous transmission by chiggers.
Current mouse models of scrub typhus using intraperi-
toneal inoculation have provided some information about the
Table 4 | Important immunological considerations for the design of a
vaccine against scrub typhus.
• Orientia tsutsugamushi, the etiologic agent of scrub typhus,
presents remarkable genetic heterogeneity among strains and
particularly antigenic diversity of the major surface proteins
• O. tsutsugamushi can establish asymptomatic chronic infections in a
still unknown portion of patients
• The number of strains of O. tsutsugamushi is large, and the naturally
dominant immune response appears to be directed against poorly
conserved or highly variable antigens
• Both antibodies and T cells appear to play important roles; however,
homologous immunity wanes over time, and heterologous immunity
is very short-lived
• There is very limited knowledge about the correlates of protective
immunity against Orientia
• Endothelial cells, the main targets of the systemic oriential infection,
are important physiological regulators of the immune response
• The identification of immunoregulators in the saliva of the vectors,
larval trombiculid mites, has not been pursued
anti-oriential immune response; however, those models do not
produce systemic endothelial infection, which is the hallmark of
human infections with O. tsutsugamushi. Therefore, they cannot
address how O. tsutsugamushi is cleared from endothelial cells
because normally secondary targets of infection, macrophages
and mesothelial cells, are the main targets of infection in mice
infected intraperitoneally. Discovery of mechanisms of protective
immunity and identification of correlates of protective immu-
nity are only possible in the context of an animal model in
which endothelial cells are the main target cells of infection
because successful effector mechanisms need to be active in or
against endothelial cells. This consideration is important because
endothelial cells interact closely with leukocytes as part of their
physiological function. Some of these aspects as related to rick-
ettsioses have recently been reviewed (Valbuena andWalker, 2006,
2009).
We propose that a modern approach to vaccine develop-
ment against scrub typhus will require the development of more
appropriate animal models and should be guided by two general
overarching principles: (1) identification of relevant antigens that,
in combination, can stimulate all relevant branches of adaptive
immunity, namely antibodies, CD4+ T cells, and CD8+ T cells;
and (2) definition of immunological correlates of protection to
guide the selection of vehicles, vectors, schedules, and adjuvants.
In this regard, it will be important to identify new correlates of
protection and/or adapt modern correlates of protection identi-
fied in humans and other models of intracellular infection. For
instance, now we know that there is functional heterogeneity
of the T cell effector responses (including cytokine secretion,
cytolytic activity, and development of various memory pheno-
types) and that there are particular subsets of T cells, which
express unique combinations of effector functions, that are more
protective (Wu et al., 2002; Darrah et al., 2007; Miller et al., 2008;
Akondy et al., 2009; Lindenstrøm et al., 2009).
Given that human adaptive immunity against O. tsutsuga-
mushi (as well as that of NHPs) is not sufficiently cross-reactive,
wanes over time, and is not even sterilizing, it will be difficult to
identify truly predictive correlates of protective immunity from
the analysis of human or NHP samples. A possible solution to
identifying relevant correlates of protective immunity might be
found in the analysis of immunity against spotted fever rick-
ettsioses (Rickettsia is phylogenetically the closest to Orientia)
since immunity against the rickettsiae that cause spotted fevers
is sterilizing and long lasting (Valbuena, 2012); however, one
problem is that there is still very little information about the T
cell response of humans against Rickettsia. An alternative source
of information about correlates of protective immunity against
intracellular pathogens in humans can be derived from the study
of the immune response against the two most successful vaccines
(that include T cell immunity) produced thus far, namely vac-
cinia, the smallpox vaccine, and 17D, the yellow fever vaccine
(Gaucher et al., 2008; Akondy et al., 2009; Querec et al., 2009).
Excellent reviews on these topics have been published recently
(Miller et al., 2008; Pulendran, 2009; Liu et al., 2010; Ahmed and
Akondy, 2011). The most important points to highlight are that
effective immunity can be predicted by the integrated analysis
of multiple parameters including the following: (1) the rapidity
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and magnitude of the primary T cell response (as determined
by increased expression of activation markers such as HLA-DR,
CD38, Ki-67, CD154, and decreased expression of Bcl-2); (2)
effector CD8+ T cells expression of IFN-γ, perforin and granzyme
B; (3) effector and memory cells production of a mixture of
various cytokines (even mixed Th1/Th2 cytokines); (4) mem-
ory cells that have a bimodal distribution consisting of both
effector memory and central memory phenotypes; (5) rapid acti-
vation of both innate (especially NK cells) and adaptive immune
cells; (6) persistence of the response over time; (7) early up-
regulation of master transcriptional regulators of innate and
adaptive immunity such as ETS2, IRF1, IRF7, IRF8, STAT1, and
FOXO3a.
Our current knowledge of immunity against O. tsutsuga-
mushi from animal models and natural and experimental human
infections suggests the following features: (1) humoral and cel-
lular adaptive immunity act in concert to produce the best
outcomes; (2) protective immunological memory against het-
erologous strains is very short-lived; and (3) the protective
memory response against homologous strains lasts much longer
but also seems to wane over time. The following scenario
could explain these phenomena: during natural O. tsutsuga-
mushi infections, immunodominant antigens recognized by the
humoral and cellular immune responses are mainly encoded
by genes that are not conserved among different strains of
O. tsutsugamushi, while conserved genes encode subdominant
or cryptic antigens. Since the response against immunodom-
inant antigens results in a “suppressed” or masked response
against subdominant antigens, the resultant absolute number
of possible memory cells capable of recognizing conserved
(i.e., cross-reactive) antigens is very limited and is expected to
wane more rapidly. There are compatible data in support of
this scenario for the anti-oriential humoral immune response
since immunodominant antigens, such as the 56 kDa surface
proteins, are highly variable antigens among different strains
of O. tsutsugamushi, and these antigens provide very limited
cross-protection.
We believe that immunization with a combination of con-
served Orientia antigens recognized, as a whole, by CD4+ T cells,
CD8+ T cells, and antibodies will lead to anti-oriential immunity
that is sterilizing, cross-reactive, and sustained. For the iden-
tification of the relevant antigens, we advocate the use of an
empirical approach to antigen discovery, i.e., testing of all possi-
ble conserved antigens for immunogenicity (for both T cells and
B cells) and protection because there is not sufficient evidence
that predictions from the bioinformatics approaches of reverse
vaccinology (analysis of complete microbial genomes to predict
immunogenic proteins based on predefined rules derived from
the analysis of large empirical datasets) are truly comprehensive
and maximally accurate. Although these approaches have gener-
ally identified protective antigens (Rinaudo et al., 2009; Sette and
Rappuoli, 2010), an entire microbial genome has not been exper-
imentally screened in order to determine the proportion of truly
antigenic proteins that were predicted through bioinformatics
approaches. There is experimental evidence that those predictions
are very limiting (Wu et al., 2011). In fact, using predictive algo-
rithms in bioinformatics approaches, known protective bacterial
antigens actually have less predicted epitopes recognized by T cells
than randomly selected bacterial protein sets used as a control
(Halling-Brown et al., 2008).
A comprehensive discovery program for cross-reacting anti-
gens of O. tsutsugamushi guided by genomic information, which
has not been attempted to date, is likely to yield the most rele-
vant vaccine candidates. This approach is now possible because
genomic information, although limited to two strains, is now
available (Cho et al., 2007; Nakayama et al., 2008, 2010) and
is expected to keep growing. The construction of libraries
with all conserved open-reading-frames (ORFs) of Orientia (the
ORFeome) is possible through PCR-mediated amplification of
those ORFs or through gene synthesis; those genes can then be
expressed in histocompatible antigen presenting cells (APCs).
Such a project is feasible because the number of conserved
genes is not excessive; if one includes the genomes of several
species of Rickettsia to determine the most conserved genes, the
number is about 500 genes (Nakayama et al., 2010). Although
anti-Orientia immune T cells could be used for screening and
antigen detection, those T cells would necessarily be memory
cells that can only recognize immunodominant epitopes; that
is, of course, the nature of a physiological immune response.
Thus, the resultant candidates may not be protective because,
as explained previously, O. tsutsugamushi can establish chronic
infections in the face of an immune response against immun-
odominant antigens. Consequently, we propose that a better
antigen identification method would consist of in vivo screen-
ing in immunologically naive animals (Figure 1); such animals
would be vaccinated with APCs expressing conserved ORFs from
O. tsutsugamushi or, alternatively, with appropriate vaccine DNA
vectors expressing those ORFs. This second option is similar
to expression library immunization (ELI) (Sykes, 2008). This
method, like the one we propose, allows the priming of naïve
T cells by the expressed cloned microbial genes regardless of
whether they are subdominant or dominant during a natural
infection as long as the appropriate T cell receptors are present;
however, it relies on a DNA immunization strategy so anti-
gen expression is not guaranteed in all cases. In either method,
protection from challenge with O. tsutsugamushi would iden-
tify subdominant or cryptic antigens among those proteins of
O. tsutsugamushi encoded by conserved genes. This approach
is likely to identify immunogenic and protective proteins from
the normally subdominant pool of proteins. This outcome will
likely be the case given the evidence from other models of
intracellular infection that vaccination against subdominant epi-
topes can produce effective cellular immune responses (Riedl
et al., 2009; Ruckwardt et al., 2010; Im et al., 2011). An addi-
tional consideration that would support our approach is that,
from the perspective of the T cell response, cross-reactivity is
also favored by the T cells themselves since the T cell recep-
tor is multispecific due to structural flexibility and interac-
tions with only a few residues within the presented peptides.
Thus, the T cell repertoire has a tremendous capacity for cross-
reactivity (Mason, 1998; Sewell, 2012). If resources are not
available for testing all conserved ORFs, the testing could be pri-
oritized using other criteria including antigenicity predictions
(with the caveats already mentioned) and levels of expression of
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FIGURE 1 | Diagram of a strategy to discover subdominant antigens recognized by T cells.
bacterial proteins in vivo (Rollenhagen et al., 2004; Mahdi et al.,
2012).
Unlike the system just proposed, most other techniques for
identification of antigens recognized by T cells use immune T cells
(i.e., memory T cells) to detect positive reactions; therefore, they
are biased by immunodominance, which is, as mentioned ear-
lier, not useful in the case of scrub typhus. Examples of those
techniques include screening of retrovirus-based cDNA libraries
(Wang et al., 1998; Aoshi et al., 2005), use of random expres-
sion genomic libraries in E. coli to feed macrophages as APCs
(Gonçalves et al., 2006), screening of purified proteins (from a
genomic library) coupled to beads (Valentino et al., 2011a,b),
screening of synthetic minigene libraries (Hondowicz et al.,
2012), and screening of plasmid-encoded combinatorial peptide
libraries (Siewert et al., 2012).
After the identification of a combination of antigens
that together can stimulate protective responses mediated by
CD8+T cells, CD4+T, and B cells (antibodies), the next devel-
opmental step for a modern anti-Orientia vaccine will be the
selection of the best strategy to optimally stimulate those immune
system cells. The objective is to do better than nature by testing
different adjuvants, immunization routes, and schedules. These
concepts are evolving very rapidly; thus, the reader is referred
to recent reviews (Coffman et al., 2010; Liu, 2010). This testing
must be done in appropriate animal models, thus the generation
of relevant animal models to identify correlates of protective
immunity and to test vaccine candidates is essential in the vaccine
development effort against scrub typhus. Non-human primates
constitute excellent models because scrub typhus pathogenesis
and immunity are very similar to that of humans; however, the
high cost of these animals together with the necessity of per-
forming experiments with O. tsutsugamushi in a biosafety-level-3
(BSL-3) environment preclude their general and consistent use.
Although there are fundamental biological species differences
between humans and mice that are likely to affect direct trans-
lation to humans (Marian, 2011), very valuable information can
be obtained from mice as long as there is a serious attempt to
mimic the pathophysiology of humans. The ideal model should
include transmission by chiggers, and some progress has already
been made in that direction (see earlier sections on this topic).
Alternatively, intradermal injection of O. tsutsugamushi to mimic
the natural path of infection may be more reproducible and
easier to implement. Our group is currently developing this
model in C3H/HeN mice infected with the Karp strain; results
are very promising since the infection is systemic and predomi-
nantly endothelial (Figure 2). We have also developed an intra-
venous infection model with similar results; the reports of these
models are forthcoming. Another model that may provide an
improved bridge to direct translation for human studies is that
provided by humanized mice. These are highly immunodeficient
mice (Hiramatsu et al., 2003; Brehm et al., 2010; McDermott
et al., 2010) transplanted with human hematopoietic stem cells
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FIGURE 2 | Immunohistochemical detection of oriential antigen.
(A) Analysis performed in the brain of a C3H/HeN mouse infected i.v.,
with 2× 105 FFU of Orientia tsutsugamushi 11 days earlier (original
magnification 400×). Alkaline phosphatase signal from the secondary
antibody produces a red precipitate visible in endothelial cells of a
microvessel (arrows) and in adjacent mononuclear leukocytes (asterisks).
The section is counterstained with hematoxylin and eosin. (B) Analysis of
the lungs of the same animals (original magnification 100×) with the
same alkaline phosphatase technique shows multiple foci of oriential
antigen in the alveolar walls. Courtesy of Thomas Shelite.
to reconstitute the human hematolymphoid system. Since these
humanized mice can mount adaptive human immune responses,
they provide a relevant model for translational research (Shultz
et al., 2007) and the study of infectious diseases (Rämer et al.,
2011).
CONCLUSION
Scrub typhus is a truly neglected vector-transmitted intracellular
bacterial infection that causes significant morbidity and mor-
tality in a large geographical area of the world. A prophylactic
vaccine is a public health priority because of its high incidence,
high mortality, non-specific clinical presentation, lack of sensi-
tive diagnostic tests, and emergence of antibiotic resistance. For
the last 60 years, continuous efforts to develop a vaccine have
not succeeded because they have not been able to address and
overcome the inability of the natural immune response against
Orientia to produce sterilizing, long-lasting, and cross-protective
immunity. This inappropriate immune response appears to be a
consequence of natural immunodominance of antigens encoded
by oriential genes that are not conserved among a large number of
strains. However, current technological advances, together with
approaches rooted in a deep general understanding of effective
human immune responses, will help address the current barriers
to vaccine development against Orientia tsutsugamushi.
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